UroGen Pharma URGN EPS (Diluted)
Discontinued — last reported Q2 '21
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by UroGen Pharma in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasicAndDiluted.
The official record: UroGen Pharma’s 10-Q, filed August 4, 2021, on SEC EDGAR. View the filing →
Ask your AI about UroGen Pharma's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is UroGen Pharma's EPS (diluted)?
- UroGen Pharma (URGN) reported EPS (diluted) of -$1.17 in Q2 2021.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.